Previous studies have also shown that high RAC3 expression was associated with poor survival in lung adenocarcinoma, bladder cancer and breast cancer et al.12, 19, 22Recent studies highlighted significant roles of the RAC3 in tumour development and progression. This evidence concerns the gene RAC3 and lung adenocarcinoma.